KAISER PETER (Chief Development Officer) sold 1.0% of their position (2.81K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $23.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2026ACC: 0001104659-26-019804
Officer· Chief Development Officer
Since Feb 2026
-2.81K
Net shares
Net seller
$23.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.81K
Price / share
$8.28
Trade value
$23.27K
% of position
1.0%
2/23/2026
271.92K→269.11K
Total
Net shares
−2.81K
Net value
-$23.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | S · Sale | −2.81K | $8.28 | $23.27K | 1.0% | 271.92K | 269.11K |
| Total | −2.81K | -$23.27K | ||||||
Derivative Transactions0
No derivative transactions reported